| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-05 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |